Michael Gassen

1.1k total citations
18 papers, 950 citations indexed

About

Michael Gassen is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Gassen has authored 18 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Gassen's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Michael Gassen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Michael Gassen collaborates with scholars based in Israel, Germany and United States. Michael Gassen's co-authors include Moussa B. H. Youdim, Yelena Glinka, Aviva Gross, Silvia Mandel, Edna Grünblatt, Johann Leban, Roland Baumgartner, Jan Mies, Gabriela Pergande and Gerhard Bringmann and has published in prestigious journals such as Journal of Chromatography A, Tetrahedron and Biochemical Pharmacology.

In The Last Decade

Michael Gassen

18 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Gassen Israel 15 433 370 280 140 116 18 950
Christine Thiffault United States 12 491 1.1× 316 0.9× 304 1.1× 123 0.9× 151 1.3× 22 1.1k
Virginia Zbarsky United Kingdom 15 219 0.5× 289 0.8× 242 0.9× 145 1.0× 178 1.5× 16 946
T Nagatsu Japan 21 319 0.7× 366 1.0× 305 1.1× 91 0.7× 134 1.2× 46 998
Helena Xicoy Netherlands 10 368 0.8× 295 0.8× 453 1.6× 218 1.6× 142 1.2× 11 1.1k
Justine Renaud Canada 23 178 0.4× 315 0.9× 597 2.1× 245 1.8× 163 1.4× 32 1.4k
Aviva Gross Israel 12 367 0.8× 283 0.8× 169 0.6× 152 1.1× 70 0.6× 15 845
Jae‐Hyung Bach South Korea 19 203 0.5× 338 0.9× 462 1.6× 162 1.2× 173 1.5× 27 1.2k
Rajeswara Babu Mythri India 14 325 0.8× 265 0.7× 409 1.5× 342 2.4× 146 1.3× 20 1.2k
Laura P. Bernard United States 15 187 0.4× 229 0.6× 340 1.2× 166 1.2× 85 0.7× 18 827
Sarika Singh India 24 267 0.6× 221 0.6× 465 1.7× 230 1.6× 214 1.8× 57 1.4k

Countries citing papers authored by Michael Gassen

Since Specialization
Citations

This map shows the geographic impact of Michael Gassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gassen more than expected).

Fields of papers citing papers by Michael Gassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gassen. The network helps show where Michael Gassen may publish in the future.

Co-authorship network of co-authors of Michael Gassen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gassen. A scholar is included among the top collaborators of Michael Gassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gassen. Michael Gassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Leban, Johann, et al.. (2005). Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 267–270. 21 indexed citations
2.
Leban, Johann, et al.. (2005). SAR, species specificity, and cellular activity of cyclopentene dicarboxylic acid amides as DHODH inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(21). 4854–4857. 31 indexed citations
3.
Mattsson, Cecilia, Clas Sonesson, Hartmut E. Greiner, et al.. (2005). 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(19). 4230–4234. 49 indexed citations
4.
Mattsson, Cecilia, et al.. (2005). 2‐Alkyl‐3‐(1,2,3,6‐tetrahydropyridin‐4‐yl)‐1H‐indoles as Novel 5‐HT6 Receptor Agonists.. ChemInform. 36(51). 8 indexed citations
5.
Gassen, Michael, et al.. (2003). Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation. Journal of Neural Transmission. 110(2). 171–182. 16 indexed citations
6.
Youdim, Moussa B. H., Michael Gassen, Aviva Gross, Silvia Mandel, & Edna Grünblatt. (2000). Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine. PubMed. 83–96. 29 indexed citations
7.
Grünblatt, Edna, Silvia Mandel, Michael Gassen, & Moussa B. H. Youdim. (1999). Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity. PubMed. 55. 57–70. 31 indexed citations
8.
Gassen, Michael & Moussa B. H. Youdim. (1999). Free radical scavengers: chemical concepts and clinical relevance. Journal of neural transmission. Supplementum. 56. 193–210. 48 indexed citations
9.
Gassen, Michael, Aviva Gross, & Youdim Mb. (1999). Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties.. PubMed. 80. 297–302. 19 indexed citations
10.
Gassen, Michael, Aviva Gross, & Moussa B. H. Youdim. (1998). Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐hydroxydopamine. Movement Disorders. 13(2). 242–248. 119 indexed citations
11.
Gassen, Michael, Gabriela Pergande, & Moussa B. H. Youdim. (1998). Antioxidant properties of the triaminopyridine, flupirtine. Biochemical Pharmacology. 56(10). 1323–1329. 23 indexed citations
12.
Gassen, Michael, Aviva Gross, & Moussa B. H. Youdim. (1998). Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine. Movement Disorders. 13(4). 661–667. 40 indexed citations
13.
Gassen, Michael, et al.. (1997). Apomorphine Is a Potent Radical Scavenger and Protects Cultured Pheochromocytoma Cells from 6-OHDA and H2O2-Induced Cell Death. Advances in pharmacology. 42. 320–324. 16 indexed citations
14.
Glinka, Yelena, Michael Gassen, & Moussa B. H. Youdim. (1997). Mechanism of 6-hydroxydopamine neurotoxicity. Journal of neural transmission. Supplementum. 50. 55–66. 292 indexed citations
15.
Gassen, Michael & Moussa B. H. Youdim. (1997). The Potential Role of Iron Chelators in the Treatment of Parkinson's Disease and Related Neurological Disorders. Pharmacology & Toxicology. 80(4). 159–166. 63 indexed citations
16.
Gassen, Michael, et al.. (1996). Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. European Journal of Pharmacology. 308(2). 219–225. 124 indexed citations
17.
Bringmann, Gerhard, Michael Gassen, & Stefan W. Schneider. (1994). Toxic aldehydes formed by lipid peroxidation I. Sensitive, gas chromatography-based stereoanalysis of 4-hydroxyalkenals, toxic products of lipid peroxidation. Journal of Chromatography A. 670(1-2). 153–160. 14 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Thiffault Breakdown of academic impact, for papers by Virginia Zbarsky Breakdown of academic impact, for papers by T Nagatsu Breakdown of academic impact, for papers by Helena Xicoy Breakdown of academic impact, for papers by Justine Renaud Breakdown of academic impact, for papers by Aviva Gross Breakdown of academic impact, for papers by Jae‐Hyung Bach Breakdown of academic impact, for papers by Rajeswara Babu Mythri Breakdown of academic impact, for papers by Laura P. Bernard Breakdown of academic impact, for papers by Sarika Singh
Rankless by CCL
2026